Delivery Order SPE2DB22D1202-SPE2DB25FVKS0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,667.30 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in respiratory therapy, on August 14, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, and represents fulfillment under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $10,713.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 (a combination inhalation powder medication for chronic obstructive pulmonary disease) in a 60-dose package. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $14,019.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,586.56 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 21, 2025. AmerisourceBergen will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,085.54 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The non-set-aside, firm fixed price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order represents a single pharmaceutical transaction executed under AmerisourceBergen's broader federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.25 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive set-aside procurement. The contract specifies performance at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.67 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on July 24, 2025, with a completion date of July 25, 2025, and represents a non-set-aside competitive procurement. The award was issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $3,850.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,024.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used for chronic obstructive pulmonary disease management. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKS0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,431.59 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026 that enables the company to deliver pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company has established a strong track record with DLA through competitively awarded contracts featuring firm fixed pricing across a diverse portfolio of pharmaceutical products, vaccines, and medical supplies. As a major healthcare solutions provider, AmerisourceBergen maintains the capability to fulfill federal procurement requirements at varying order values, ranging from minimal transactions to substantial orders exceeding $45,000, demonstrating its importance to the military's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/8/25 |